tirzepatide alopecia has been reported as a possible side effect of GLP-1 receptor agonists, particularly semaglutide and tirzepatide. A new study took a closer look. Read about the findings via the link in Improvement of Recalcitrant Folliculitis Decalvans

The statements made on this website have not been evaluated by the US Food and Drug Administration (FDA)

The abdomen (avoiding a two-inch radius around the navel) and front and outer thighs are appropriate sites for self-injection

As an independent pathological entity, hyperuricemia extends beyond gout pathogenesis to contribute to systemic comorbidities, including atherosclerosis, chronic kidney disease, and metabolic syndrome

Want To Learn More About GLP-1 Injections

It is the first drug in this class of medications to be approved and released for type 2 diabetes and weight management

With obesity impacting the health and welfare of 42% of adults and costing the U.S